Your search history is turned on.
Date: May 1, 2024 Jurisdictions: Alberta, British Columbia, Ontario
HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth Vancouver, British Columbia May 01, 2024 - HYTN Innovations Inc. (CSE: HYTN HYTN or The Company), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, applauds the recent formal recommendat...
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
SUPPLEMENTAL MAILING LIST REQUEST FORM CONSENT Annual General Meeting of Shareholders held May 23, 2024 (the Issuer) Request for Financial Statements In accordance with National Instrument 51-102 Continuous Disclosure Obligations, registered and beneficial shareholders may elect annually to receive interim (quarterly) financial statements and corr...
HYTN INNOVATIONS INC. Voting Instruction Form (VIF) Annual General Meeting to be held on Thursday, May 23, 2024 United Kingdom Building 350 409 Granville Street Vancouver BC V6C 1T2 Appointment of Appointee I/We being the undersigned holder(s) of HYTN I...
HYTN INNOVATIONS INC. Form of Proxy Annual General and Special Meeting to be held on Thursday, May 23, 2024 Traders Bank Building 702, 67 Yonge Street Toronto ON M5E 1J8 Appointment of Proxyholder I/We being the undersigned holder(s) of HYTN Innovations Inc....
NOTICE OF MEETING AND MANAGEMENT INFORMATION CIRCULAR FOR ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF HYTN INNOVATIONS INC. Dated Effective April 18, 2024 HYTN INNOVATIONS INC. ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that an annual general and special meeting (the Meeting...
Date: April 22, 2024 Jurisdictions: Alberta, British Columbia, Ontario
HYTN Innovates GMP Stability Programs, Sets Industry Benchmark Vancouver, British Columbia April 22, 2024 - HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) HYTN or The Company, a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, is pleased to announce signif...
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Ontario
HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities Vancouver, British Columbia April 9, 2024 - HYTN Innovations Inc. (CSE: HYTN, HYTN or The Company), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, welcomed Health Canadas conduct of a Drug ...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Ontario
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company HYTN Innovations Inc. (the Company) 12 East 4th Avenue Vancouver, BC Canada V5T 1E8 Item 2 Date of Material Change April 3, 2024 Item 3 News Release The Company disseminated a news release announcing the material change describe...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
HYTN Provides Corporate Update, Outlines New Global Direction One of the only Canadian firms meeting the stringent specifications of both the German Pharmacopoeia and European Pharmacopoeia for Cannabis Flower Vancouver, British Columbia April 3, 2024 - HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0, "HYTN or The Company"), a leader in the d...